SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001479290-17-000003
Filing Date
2017-01-05
Accepted
2017-01-05 16:34:05
Documents
3
Period of Report
2017-01-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rvnc8k1517.htm 8-K 28676
2 EXHIBIT 99.1 rvncex9911517.htm EX-99.1 46597
3 GRAPHIC rvncnewlogoa09.jpg GRAPHIC 26009
  Complete submission text file 0001479290-17-000003.txt   112326
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 17511193
SIC: 2834 Pharmaceutical Preparations